Vip 6 mg

Technical Details

Dosage & Usage Guidelines

Typical preclinical studies use VIP at 2–6 mg per week, divided into subcutaneous or intravenous injections. Due to its short half-life in vivo, some research protocols utilize stabilized formulations or frequent dosing. VIP is not bioavailable orally and should be handled with sterile technique under lab-controlled conditions.

Synergistic Peptides for Research Stacking

Researchers commonly combine VIP with other anti-inflammatory or neuroactive peptides for synergistic benefit:

• BPC-157 – for GI tract healing and gut-brain axis studies
• Selank – supports neuroimmune balance and stress regulation
• GHK-Cu – for regenerative and anti-inflammatory synergy
• SS-31 – mitochondrial protection and oxidative stress modulation
• Thymalin – systemic immune normalization in aging and chronic disease models

Safety Profile

VIP has demonstrated a favorable safety profile in early human trials and preclinical models. It does not affect sex hormones or metabolic functions and shows no evidence of toxicity to liver, kidney, or cardiovascular systems. Because of its short half-life, dosing protocols may require precision timing or peptide stabilization methods.

USA Domestic Shipping & Quality Control

Peptide Hubs provides fast and discreet USA domestic shipping for VIP 6 mg and all peptide research products. Every vial is manufactured in GMP-compliant labs and batch-tested for purity and sterility. VIP is a high-value research tool for gastrointestinal, neurological, and immune applications.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions